Premium
Inclusion of Pediatric Samples in an Opt‐Out Biorepository Linking DNA to De‐Identified Medical Records: Pediatric BioVU
Author(s) -
McGregor T L,
Van Driest S L,
Brothers K B,
Bowton E A,
Muglia L J,
Roden D M
Publication year - 2013
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2012.230
Subject(s) - biorepository , inclusion (mineral) , medicine , medical record , biobank , psychology , genetics , biology , social psychology
The Vanderbilt DNA repository, BioVU, links DNA from leftover clinical blood samples to de‐identified electronic medical records (EMRs). After initiating adult sample collection, pediatric extension required consideration of ethical concerns specific to pediatrics and implementation of specialized DNA extraction methods. In the first year of pediatric sample collection, more than 11,000 samples from individuals younger than 18 years were included. We compared data from the pediatric BioVU cohort with those from the overall Vanderbilt University Medical Center pediatric population and found similar demographic characteristics; however, the BioVU cohort had higher rates of select diseases, medication exposures, and laboratory testing, demonstrating enriched representation of severe or chronic disease. The fact that the sample accumulation is not balanced may accelerate research in some cohorts while limiting the study of relatively benign conditions and the accrual of unaffected and unbiased control samples. BioVU represents a feasible model for pediatric DNA biobanking but involves both ethical and practical considerations specific to the pediatric population. Clinical Pharmacology & Therapeutics (2013); 93 2, 204–211. doi: 10.1038/clpt.2012.230